EYENOVIA, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.833 USD | +10.92% |
|
+45.07% | -59.30% |
Chart calendar Eyenovia, Inc.
ff6a7a73c683d0a.7obfRP9KSdh8Ki_T1aHbJ5qO71naasaDoXJRVUN5lmc.osCyM6wnf5A-R3u_5-mLH8z_2WCwWJ_J9RUDYwU4rwiq8pYNtSkMsx9FFw~76c12547a74b582e362f402e1a1a2932
Upcoming events on Eyenovia, Inc.
Past events on Eyenovia, Inc.
| 10/04/2024 | Vison Source Exchange Conference |
| 05/04/2024 | American Society of Cataract and Refractive Surgery Meeting |
| 19/03/2024 02:00 am | Q4 2023 Earnings Call |
| 19/03/2024 01:35 am | Q4 2023 Earnings Release |
| 25/01/2024 | FORCE Family Office Healthcare Conference |
| 14/11/2023 03:00 am | Q3 2023 Earnings Call |
| 14/11/2023 02:35 am | Q3 2023 Earnings Release |
| 13/10/2023 03:00 am | American Academy of Optometry Meeting - Poster No 36 |
| 26/09/2023 10:30 pm | Cantor Global Healthcare Conference - Panel |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 16/08/2023 07:30 pm | H.C. Wainwright Ophthalmology Virtual Conference - Panel |
| 16/08/2023 04:30 pm | H.C. Wainwright Ophthalmology Virtual Conference |
| 11/08/2023 02:00 am | Q2 2023 Earnings Call |
| 11/08/2023 01:35 am | Q2 2023 Earnings Release |
| 27/06/2023 07:30 pm | Annual General Meeting |
| 10/06/2023 | OCTANE Ophthalmology Tech Forum |
| 12/05/2023 02:00 am | Q1 2023 Earnings Call |
| 12/05/2023 01:35 am | Q1 2023 Earnings Release |
| 25/04/2023 10:15 pm | Association for Research in Vision and Ophthalmology Meeting |
| 31/03/2023 02:00 am | Q4 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 2,00 0,00 - | 14,0 4,00 250% | 0,00 0,00 - | 0,00 0,42 -99.11% | 5,23 |
|
EBITDA Million USD | Released Forecast Spread | -21,3 -21,0 -1.4% | 0,00 0,00 - | -12,7 -18,8 32.6% | 0,00 0,00 - | 0,00 0,00 - | -64,6 |
|
EBIT Million USD | Released Forecast Spread | -21,3 -21,6 1.19% | -19,8 -20,9 5.51% | -12,9 -21,7 40.62% | -26,9 -28,7 6.2% | -25,4 -25,3 -0.38% | -31,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,2 -21,6 1.92% | -19,8 -20,9 5.49% | -12,8 -22,1 42.28% | -28,0 -29,1 3.59% | -27,3 -26,9 -1.22% | -32,1 |
|
Net income Million USD | Released Forecast Spread | -21,2 -21,6 1.92% | -19,8 -20,9 5.49% | -12,8 -21,7 41.15% | -28,0 -29,1 3.59% | -27,3 -26,9 -1.22% | -32,1 |
|
EPS USD | Released Forecast Spread | -1,47 -1,51 2.78% | -0,94 -1,00 5.53% | -0,49 -0,85 42.35% | -0,83 -0,88 5.14% | -0,66 -0,68 3.3% | -0,69 |
| Announcement Date | 25/03/20 | 25/03/21 | 28/03/22 | 30/03/23 | 18/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 10,0 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,16 -99.23% | 0,00 0,12 -97.92% | 0,64 | 0,79 | 1,12 | 1,58 |
|
EBITDA Million USD | Released Forecast Spread | 3,19 -4,45 171.61% | -6,20 -5,60 -10.77% | -6,01 -5,95 -1.08% | -6,22 -5,95 -4.51% | |||||||||
|
EBIT Million USD | Released Forecast Spread | 3,11 -5,94 152.39% | -7,19 -6,50 -10.58% | -7,12 -6,55 -8.72% | -7,23 -6,84 -5.73% | -5,37 -7,15 24.88% | -5,46 | -5,96 -6,43 7.36% | -6,52 -7,06 7.62% | -7,47 -6,97 -7.09% | -7,75 | -7,99 | -8,04 | -8,11 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,98 -6,38 146.78% | -7,34 -6,45 -13.79% | -7,24 -6,55 -10.52% | -7,31 -7,04 -3.8% | -6,12 -7,17 14.54% | -5,74 | -6,22 -6,55 5.1% | -7,34 -7,24 -1.38% | -7,97 -7,23 -10.23% | -7,97 | -8,20 | -8,26 | -8,32 |
|
Net income Million USD | Released Forecast Spread | 2,98 -5,69 152.47% | -7,34 -6,45 -13.79% | -7,24 -6,54 -10.77% | -7,31 -6,87 -6.43% | -6,12 -7,17 14.54% | -5,74 | -6,22 -6,55 5.1% | -7,34 -7,24 -1.38% | -7,97 -7,23 -10.23% | -7,97 | -8,20 | -8,26 | -8,32 |
|
EPS USD | Released Forecast Spread | 0,10 -0,22 146.15% | -0,24 -0,23 -4.35% | -0,22 -0,22 0% | -0,21 -0,20 -5% | -0,17 -0,21 17.07% | -0,15 | -0,16 -0,18 8.57% | -0,18 -0,18 0% | -0,16 -0,18 8.57% | -0,17 | -0,18 | -0,18 | -0,18 |
| Announcement Date | 28/03/22 | 12/05/22 | 10/08/22 | 10/11/22 | 30/03/23 | 12/05/23 | 10/08/23 | 13/11/23 | 18/03/24 | - | - | - | - |
| Today 01:35 am | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| Today 01:35 am | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 02/05/2024 | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| 02/05/2024 | AMGEN INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:00 am | NOVO NORDISK A/S: Q1 2024 Earnings Release |
| 02/05/2024 05:00 pm | ORGANON & CO.: Q1 2024 Earnings Release |
| 03/05/2024 | SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected) |
| 03/05/2024 | AARTI DRUGS LIMITED: Q4 2024 Earnings Release |
| 03/05/2024 | ALK-ABELLÓ A/S: Q1 2024 Earnings Release |
| 03/05/2024 | DEVA HOLDING: Q1 2024 Earnings Release (Projected) |
Past sector events for Eyenovia, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EYEN Stock
- Calendar Eyenovia, Inc.
